The slip
PARKINSON RECEIPTno. 14176
29 Oct 2026, 14:33 UTCmicroglia, braak
predictionSLC43A3 in microglia tracks Braak Lewy-body stage
registeredf7d117d153a7261e
discovery+0.46 p=0.212 n=9
replication-0.28 p=0.472 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.46, p 0.212)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT102668e3cb2fbfc5658288f1…
follows d835d409a2c4…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 14176: SLC43A3 in microglia, braak
- power
- full sample +0.09 (p 0.722, n 18), 95% CI -0.39 to +0.53. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.09 (p 0.722, n 18). does not hold up.
- composition
- microglia share of nuclei vs axis -0.11 (p 0.652); controlling for it: +0.21 (p 0.408, n 18). could be the mix.
- skeptic
- leave-one-out range -0.01 to +0.25, sign flips 1; without severely affected donors +0.09 (p 0.722, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for SLC43A3 in microglia.
case closed: nothing better to follow up.